| | | |
SFA 12wk
|
|---|
| |
↓
| |
|---|
| |
LF 20wk
|
SFA 20wk
|
LF + At 8wk
|
SFA + At 8wk
|
LF + Pr 8wk
|
SFA + Pr 8wk
|
LF + Ib 8wk
|
SFA + Ib 8wk
|
|---|
|
Cholesterol (mM)
|
1.64 ± 0.14
|
1.43 ± 0.08
|
1.17 ± 0.11a
|
1.55 ± 0.14
|
1.52 ± 0.17
|
1.37 ± 0.09
|
1.81 ± 0.26
|
1.19 ± 0.11a
|
|
Triglycerides (mM)
|
0.80 ± 0.12
|
0.55 ± 0.14
|
0.40 ± 0.04a
|
0.63 ± 0.09
|
0.89 ± 0.09b
|
1.00 ± 0.17b
|
0.57 ± 0.07
|
0.80 ± 0.14
|
|
NEFA (mEq/L)
|
0.70 ± 0.04
|
0.61 ± 0.07
|
0.50 ± 0.07a
|
0.62 ± 0.05
|
0.62 ± 0.06
|
0.51 ± 0.04a
|
0.52 ± 0.04a
|
0.52 ± 0.06a
|
- The table shows the effects of various feeding regimens on plasma lipids. Plasma total cholesterol, triglycerides and non-esterified fatty acids (NEFA) were measured at the end of the feeding regimen. Data represented as mean ± standard error of mean. Means were compared with non-parametric independent t test, where P < 0.05 considered statistically significant.
- a: statistically significant in comparison to LF.
- b: statistically significant in comparison to SFA.
- Abbreviations: LF, low-fat; SFA, saturated fatty acids; At, atorvastatin; Pr, pravastatin; Ib, ibuprofen; wk, weeks.
